Phishing warning 01-May-2024
We are aware of phishing emails targeting speakers of events whose names appear on our events pages. If you are unsure if an email regarding event registration or accommodation has come from us please contact us and do not provide any credit card details or personal information.

4th Exosome Based Therapeutic Development Summit

4 October 2022 09:00 - 6 October 2022 17:00, Needham, United States


Introduction
Built with biopharmaceutical industry insights, this in-person conference will delve into different types of extracellular vesicles (EVs) from various cell sources as a solution to deliver treatments safely and effectively. Learn how to optimize your translational route towards safe and effective clinical development in a broad range of diseases.

With 3 days of unrivaled content and two dedicated tracks, this year's summit will be putting the spotlight on cutting-edge strategies from discovery, translation, and clinical development of modified and unmodified exosomes and EVs, to accelerate this emerging field forward.

Whether you are challenged by characterization, scale-up manufacturing or regulatory considerations of your EVs or simply are looking to optimize your translational route towards safe and effective clinical development, you will find this year's summit your one-stop shop to gain meaningful insights and cutting-edge data.

Tailor-made to showcase the latest innovations and interactively discuss the industry's most important talking points, join 130+ movers and shakers of the field from the likes of Codiak BioSciences, Rion, MDimmune and Aruna Bio at this must-attend summit to successfully optimize, accelerate and scale your extracellular vesicle-based therapeutics towards the first clinical approval.
Venue
Sheraton Boston Needham Hotel

Sheraton Boston Needham Hotel, 100 Cabot Street, Needham, 02494, United States

Contact information
Search
 
 
Showing all upcoming events
Start Date
End Date
Location
Subject area
Event type

Advertisement
Spotlight


E-mail Enquiry
*
*
*
*